Subscribe to RSS
DOI: 10.1055/a-2675-6068
Introducing the New Definition and Diagnostic Criteria of Disseminated Intravascular Coagulation Released by the International Society on Thrombosis and Haemostasis in 2025

Abstract
In 2025, the International Society on Thrombosis and Haemostasis (ISTH) released updated definitions and diagnostic criteria for disseminated intravascular coagulation (DIC), reflecting advances in understanding its pathophysiology. DIC is now defined as an acquired, life-threatening condition involving systemic coagulation activation, impaired fibrinolysis, and endothelial injury. The revised framework emphasizes the condition's dynamic nature, progressing from preclinical abnormalities to overt clinical manifestations such as bleeding and organ dysfunction. A major innovation in the 2025 update is the phase-based classification of DIC: Pre-DIC, early-phase DIC, and overt DIC. Early-phase DIC—also referred to as subclinical or compensated DIC—is characterized by laboratory abnormalities preceding clinical symptoms. Overt DIC represents the advanced stage with clear evidence of coagulopathy and organ failure. Importantly, the new criteria are tailored to the underlying disease, such as sepsis, trauma, or malignancy. For example, the sepsis-induced coagulopathy score is now acknowledged as a tool for detecting early-phase DIC in septic patients. The overt DIC scoring system has been refined, including revised D-dimer thresholds: Levels >3× and >7 × , the upper normal limit now corresponds to 2 and 3 points, respectively. Platelet count, prothrombin time-international normalized ratio, and fibrinogen levels remain key indicators. The criteria also classify DIC into thrombotic and hemorrhagic phenotypes. Thrombotic DIC is marked by microvascular thrombosis and organ dysfunction, while hemorrhagic DIC is characterized by bleeding due to consumption of coagulation factors. By introducing clearer definitions and individualized approaches, these updates aim to enable earlier diagnosis and more effective management of DIC across clinical contexts.
Keywords
disseminated intravascular coagulation - definition - diagnostic criteria - sepsis - anticoagulationAuthors' Contributions
T.I. and C.L.M. wrote the draft. E.S. and J.H.L. reviewed and revised the manuscript, and all of the authors reviewed and approved the final version.
Publication History
Received: 12 July 2025
Accepted: 04 August 2025
Article published online:
19 August 2025
© 2025. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Iba T, Levy JH, Maier CL. et al. Updated definition and scoring of disseminated intravascular coagulation in 2025: communication from the ISTH SSC Subcommittee on Disseminated Intravascular Coagulation. J Thromb Haemost 2025; 23 (07) 2356-2362
- 2 Taylor Jr FB, Toh CH, Hoots WK, Wada H, Levi M. Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86 (05) 1327-1330
- 3 Suzuki K, Wada H, Imai H, Iba T, Thachil J, Toh CH. Subcommittee on Disseminated Intravascular Coagulation. A re-evaluation of the D-dimer cut-off value for making a diagnosis according to the ISTH overt-DIC diagnostic criteria: communication from the SSC of the ISTH. J Thromb Haemost 2018; 16 (07) 1442-1444
- 4 Lippi G, Tripodi A, Simundic AM, Favaloro EJ. International survey on D-dimer test reporting: a call for standardization. Semin Thromb Hemost 2015; 41 (03) 287-293
- 5 Iba T, Nisio MD, Levy JH, Kitamura N, Thachil J. New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey. BMJ Open 2017; 7 (09) e017046
- 6 Iba T, Levy JH, Yamakawa K, Thachil J, Warkentin TE, Levi M. Scientific and Standardization Committee on DIC of the International Society on Thrombosis and Haemostasis. Proposal of a two-step process for the diagnosis of sepsis-induced disseminated intravascular coagulation. J Thromb Haemost 2019; 17 (08) 1265-1268
- 7 Iba T, Levy JH, Warkentin TE, Thachil J, van der Poll T, Levi M. Scientific and Standardization Committee on DIC, and the Scientific and Standardization Committee on Perioperative and Critical Care of the International Society on Thrombosis and Haemostasis. Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J Thromb Haemost 2019; 17 (11) 1989-1994
- 8 Yang JY, Li LL, Fu SZ. Association analysis of sepsis progression to sepsis-induced coagulopathy: a study based on the MIMIC-IV database. BMC Infect Dis 2025; 25 (01) 573
- 9 Huang JJ, Zou ZY, Zhou ZP. et al. Effectiveness of early heparin therapy on outcomes in critically ill patients with sepsis-induced coagulopathy. Front Pharmacol 2023; 14: 1173893
- 10 Kiya GT, Abebe G, Mekonnen Z, Tadasa E, Milkias G, Asefa ET. A comparison of disseminated intravascular coagulation scoring systems and their performance to predict mortality in sepsis patients: A systematic review and meta-analysis. PLoS One 2025; 20 (01) e0315797
- 11 Delabranche X, Helms J, Meziani F. Immunohaemostasis: a new view on haemostasis during sepsis. Ann Intensive Care 2017; 7 (01) 117
- 12 Asakura H. Diversity of disseminated intravascular coagulation and selection of appropriate treatments. Int J Hematol 2021; 113 (01) 10-14
- 13 Scarlatescu E, Iba T, Maier CL. et al. Deranged balance of hemostasis and fibrinolysis in disseminated intravascular coagulation: Assessment and relevance in different clinical settings. Anesthesiology 2024; 141 (03) 570-583
- 14 Iba T, Levi M, Thachil J, Levy JH. Disseminated intravascular coagulation: The past, present, and future considerations. Semin Thromb Hemost 2022; 48 (08) 978-987
- 15 Iba T, Connors JM, Nagaoka I, Levy JH. Recent advances in the research and management of sepsis-associated DIC. Int J Hematol 2021; 113 (01) 24-33
- 16 Iba T, Helms J, Levi M, Levy JH. Thromboinflammation in acute injury: infections, heatstroke, and trauma. J Thromb Haemost 2024; 22 (01) 7-22
- 17 Thachil J. Disseminated intravascular coagulation - new pathophysiological concepts and impact on management. Expert Rev Hematol 2016; 9 (08) 803-814
- 18 Thachil J, Iba T, Scarlatescu E, Levy JH. Why is DIC a rare diagnosis in the 21st century?. Juntendo Iji Zasshi 2024; 70 (02) 121-124
- 19 Saito S, Uchino S, Hayakawa M. et al.; Japan Septic Disseminated Intravascular Coagulation (JSEPTIC DIC) study group. Epidemiology of disseminated intravascular coagulation in sepsis and validation of scoring systems. J Crit Care 2019; 50: 23-30
- 20 Chang R, Cardenas JC, Wade CE, Holcomb JB. Advances in the understanding of trauma-induced coagulopathy. Blood 2016; 128 (08) 1043-1049
- 21 Umemura Y, Scarlatescu E, Nwagha TU. et al. Mortality, diagnosis, and etiology of disseminated intravascular coagulation-a systematic review and meta-analysis: communication from the ISTH SSC subcommittee on disseminated intravascular coagulation. J Thromb Haemost 2025; 23 (08) 2663-2679
- 22 Flæng S, Granfeldt A, Sørensen HT, Adelborg K. The DANish Disseminated Intravascular Coagulation (DANDIC) Cohort Study: Time trends in incidence and short-term mortality. J Clin Med 2024; 13 (19) 5896
- 23 Koyama K, Madoiwa S, Nunomiya S. et al. Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study. Crit Care 2014; 18 (01) R13
- 24 Jackson Chornenki NL, Dwivedi DJ, Kwong AC, Zamir N, Fox-Robichaud AE, Liaw PC. Canadian Critical Care Translational Biology Group. Identification of hemostatic markers that define the pre-DIC state: A multi-center observational study. J Thromb Haemost 2020; 18 (10) 2524-2531
- 25 Kushimoto S, Wada H, Kawasugi K. et al.; Japanese Society of Thrombosis Hemostasis/DIC subcommittee. Increased ratio of soluble fibrin formation/thrombin generation in patients with DIC. Clin Appl Thromb Hemost 2012; 18 (06) 628-632
- 26 Gando S, Levi M, Toh CH. Disseminated intravascular coagulation. Nat Rev Dis Primers 2016; 2: 16037
- 27 Iba T, Levy JH, Thachil J, Susen S, Levi M, Scarlatescu E. Communication from the Scientific Standardization Committees of the International Society on Thrombosis and Haemostasis on vascular endothelium-related biomarkers in disseminated intravascular coagulation. J Thromb Haemost 2023; 21 (03) 691-699
- 28 Matsumoto H, Annen S, Mukai N. et al. Circulating Syndecan-1 levels are associated with chronological coagulofibrinolytic responses and the development of disseminated intravascular coagulation (DIC) after trauma: A retrospective observational study. J Clin Med 2023; 12 (13) 4386
- 29 Curtiaud A, Iba T, Angles-Cano E, Meziani F, Helms J. Biomarkers of sepsis-induced coagulopathy: diagnostic insights and potential therapeutic implications. Ann Intensive Care 2025; 15 (01) 12
- 30 Iba T, Umemura Y, Wada H, Levy JH. Roles of coagulation abnormalities and microthrombosis in sepsis: Pathophysiology, diagnosis, and treatment. Arch Med Res 2021; 52 (08) 788-797
- 31 Gong F, Zheng X, Zhao S. et al. Disseminated intravascular coagulation: Cause, molecular mechanism, diagnosis, and therapy. MedComm 2025; 6 (02) e70058
- 32 Yang H, Ma X, Li X. The diagnosis of DIC: A current overview. Front Med (Lausanne) 2025; 12: 1502628
- 33 Thachil J. The elusive diagnosis of disseminated intravascular coagulation: Does a diagnosis of DIC exist anymore?. Semin Thromb Hemost 2019; 45 (01) 100-107
- 34 Thachil J, Iba T. Designing the diagnostic criteria for disseminated intravascular coagulation (DIC). Juntendo Iji Zasshi 2023; 69 (06) 463-465
- 35 Iba T, Helms J, Levy JH. Sepsis-induced coagulopathy (SIC) in the management of sepsis. Ann Intensive Care 2024; 14 (01) 148
- 36 Scarlatescu E, Iba T, Maier CL. et al. Deranged balance of hemostasis and fibrinolysis in disseminated intravascular coagulation: Assessment and relevance in different clinical settings. Obstet Anesthes Dig 2025; 45 (02) 67-68
- 37 Levi M. Clinical characteristics of disseminated intravascular coagulation in patients with solid and hematological cancers. Thromb Res 2018; 164 (Suppl. 01) S77-S81
- 38 Helms J, Iba T, Connors JM. et al. How to manage coagulopathies in critically ill patients. Intensive Care Med 2023; 49 (03) 273-290
- 39 Meziani F, Iba T, Levy JH, Helms J. Sepsis-induced coagulopathy: a matter of timeline. Intensive Care Med 2024; 50 (08) 1404-1405
- 40 Yamakawa K, Okamoto K, Seki Y. et al.; Committee of the Clinical Practice Guidelines for Management of Disseminated Intravascular Coagulation 2024, the Japanese Society on Thrombosis and Hemostasis. Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 1: sepsis. Int J Hematol 2025; 121 (05) 592-604
- 41 Unar A, Bertolino L, Patauner F, Gallo R, Durante-Mangoni E. Decoding sepsis-induced disseminated intravascular coagulation: A comprehensive review of existing and emerging therapies. J Clin Med 2023; 12 (19) 6128
- 42 Shime N, Nakada TA, Yatabe T. et al. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024. J Intensive Care 2025; 13 (01) 15
- 43 Moore HB, Gando S, Iba T. et al.; Subcommittees on Fibrinolysis, Disseminated Intravascular Coagulation, and Perioperative and Critical Care Thrombosis and Hemostasis. Defining trauma-induced coagulopathy with respect to future implications for patient management: Communication from the SSC of the ISTH. J Thromb Haemost 2020; 18 (03) 740-747
- 44 Iba T, Helms J, Neal MD, Levy JH. Mechanisms and management of the coagulopathy of trauma and sepsis: trauma-induced coagulopathy, sepsis-induced coagulopathy, and disseminated intravascular coagulation. J Thromb Haemost 2023; 21 (12) 3360-3370
- 45 Hayakawa M, Seki Y, Ikezoe T. et al.; Committee of the Clinical Practice Guidelines for Disseminated Intravascular Coagulation 2024, the Japanese Society on Thrombosis, Hemostasis. Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024: part 4-trauma, burn, obstetrics, acute pancreatitis/liver failure, and others. Int J Hematol 2025; 121 (05) 633-652
- 46 Scully M, Levi M. How we manage haemostasis during sepsis. Br J Haematol 2019; 185 (02) 209-218